StemCells Therapy

MADISON, Wis.–(BUSINESS WIRE)– Stratatech Corp., a leader in regenerative medicine, today announced positive preliminary results from its ongoing clinical trial of StrataGraft, a universal human skin substitute being developed for the treatment of severe burns.

ALAMEDA, Calif.–(BUSINESS WIRE)– BioTime, Inc.

April 23, 2012 – NIST, in cooperation with Multi-Agency Tissue Engineering Science working group, is sponsoring 2-day workshop titled, Functional Imaging for Regenerative Medicine, which will explore how cutting-edge imaging techniques can advance equally fast-growing field of tissue engineering and regenerative medicine. Workshop aims to accelerate development and adoption of advanced imaging methodologies and tools by identifying current needs of tissue engineers, from molecular to macroscopic scales

SACRAMENTO, Calif., April 19, 2012 /PRNewswire/ — SynGen Inc. (“SynGen” or the “Company”), a Regenerative Medicine device company focused on the development of next generation stem cell harvesting systems, announced today that it has completed a $5 million Series A preferred stock financing with Bay City Capital, LLC (BCC)

By Dr Ananya Mandal, MD Researchers in Britain have successfully renewed a level of sight in visually impaired mice, opening the possibility that the same can be achieved in humans. The University College London researchers transplanted immature vision cells directly into the mouse retina

Regenerative medicine company Tengion (NASDAQ:TNGN) plans to start human studies on its experimental kidney disease treatment in 2013. Tengion said that it expects to file an investigational new drug application, or IND, with the U.S. Food and Drug Administration on its lead preclinical program in the first half of next year.

At the turn of the twentieth century, the promise of regenerating damaged tissue was so far-fetched that Thomas Hunt Morgan, despairing that his work on earthworms could ever be applied to humans, abandoned the field to study heredity instead. Though he won the Nobel Prize in 1933 for his work on the role of chromosomes in inheritance, if he lived today, the advances in regenerative medicine may have tempted him to reconsider

BIRMINGHAM, Alabama — The UAB College of Arts and Sciences held its third interdisciplinary innovation forum Tuesday, focusing on regenerative medicine. This can mean ways to replace failing parts of the body, or using human cells in novel systems that could speed drug discovery.

By Elizabeth Lopatto – Wed Apr 18 17:00:00 GMT 2012 Mice got new vision and revived heart muscles and monkeys were able to flex muscles in paralyzed hands in research reported today that has extended the boundaries of regenerative medicine beyond the test tube.

Tweet  In the midst of a tough environment for life science financing, cell therapy had a relatively good month. According to the our sources, cell therapy companies raised around $100 million this month.   This was done primarily by 6 companies – 5 in the US and 1 in Europe.  If one adds US-based tissue [...]

Avita Medical Ltd.

AxoGen, Inc.

AxoGen, Inc. (OTCBB: AXGN), a regenerative medicine company with a portfolio of proprietary products and technologies for peripheral nerve reconstruction and regeneration, announces the release of an updated corporate fact sheet.Alachua, FL (PRWEB) March 29, 2012 AxoGen, Inc. (OTCBB: AXGN), a leading regenerative medicine company focused on the development and commercialization of products and …

CANTON, Mass., March 27, 2012 /PRNewswire/ –Today MassBio members elected Geoff MacKay, president & CEO of regenerative medicine leader Organogenesis Inc., as chairman of the board of directors at the 2012 MassBio Annual Meeting. (Photo: http://photos.prnewswire.com/prnh/20120327/NE76866) During this year’s meeting, MassBio members also elected three new board members: Caren Arnstein, senior vice president and Head of Communications for Genzyme, James Hoyes, President of EMD Serono, Inc., and David Lucchino, CEO of Semprus BioSciences. MacKay will serve a two-year term as board chair.

WINSTON-SALEM, N.C., March 26, 2012 /PRNewswire/ –Tengion, Inc. (NASDAQ: TNGN – News), a leader in regenerative medicine, today announced that it has made significant advances in its two lead programs

Medicine’s recipe for keeping older people active and functioning in their homes and workplaces – and healing younger people injured in catastrophic accidents – may include “noodle gels” and other lab-made invisible filaments that resemble uncooked spaghetti with nanoscale dimensions, a scientist said here today at the 243rd National Meeting & Exposition of the American Chemical Society (ACS). The world’s largest scientific society, ACS is meeting here this week with reports on more than 11,000 reports on new advances in science on its schedule

WINSTON-SALEM, N.C., March 26, 2012/PRNewswire/ — Tengion, Inc. (NASDAQ: TNGN – News), a leader in regenerative medicine, today reported its financial results for the year ended December 31, 2011 and provided a business and clinical update detailed in a separate press release issued today, in which the Company reported that it has made significant advances in its two lead programs. “We have made significant progress advancing our Neo-Urinary Conduit and Neo-Kidney Augment programs and I believe we have created strong momentum to build upon as we continue to execute on our aggressive development goals in 2012,” stated John L.

Washington, Mar 26 (ANI): Medicine's recipe for keeping older people active and functioning in their homes and workplaces and healing younger people injured in catastrophic accidents may include “noodle gels” and other lab-made invisible filaments that resemble uncooked spaghetti with nanoscale dimensions, a scientist has claimed.

Public release date: 25-Mar-2012 [ | E-mail | Share ] Contact: Michael Bernstein m_bernstein@acs.org 619-525-6268 (March 23-28, San Diego Press Center) 202-872-6042 Michael Woods m_woods@acs.org 619-525-6268 (March 23-28, San Diego Press Center) 202-872-6293 American Chemical Society SAN DIEGO, March 25, 2012 Medicine’s recipe for keeping older people active and functioning in their homes and workplaces and healing younger people injured in catastrophic accidents may include “noodle gels” and other lab-made invisible filaments that resemble uncooked spaghetti with nanoscale dimensions, a scientist said here today at the 243rd National Meeting & Exposition of the American Chemical Society (ACS).

22-03-2012 12:16 Dr. Victor Dzau is a physician and pioneering translational research scientist, and is widely recognized as one of the most influential medical leaders worldwide